Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Vascular and metabolic diseases cause half of total mortality in Europe. New prognostic markers would provide a valuable tool to improve outcome. First evidence supports the usefulness of plasma lipid species as easily accessible markers for certain diseases. Here we analyzed association of plasma l...
Main Authors: | Alexander Sigruener, Marcus E Kleber, Susanne Heimerl, Gerhard Liebisch, Gerd Schmitz, Winfried Maerz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3895004?pdf=render |
Similar Items
-
Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
by: Andreas Ritsch, et al.
Published: (2020-11-01) -
Inverse association of the endogenous thrombin potential (ETP) with cardiovascular death : the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
by: Schneider, Jochen G., et al.
Published: (2015) -
Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
by: Angela P. Moissl, et al.
Published: (2023-04-01) -
Gender- and subgroup-specific sensitivity analysis of alcohol consumption and mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
by: Angela P. Moissl, et al.
Published: (2022-04-01) -
Platelet Reactivity and Cardiovascular Mortality Risk in the LURIC Study
by: Martin Berger, et al.
Published: (2023-02-01)